Process Development of the BACE Inhibitors BI 1147560 BS and BI 1181181 MZ-Reference-Cited by-同舟云学术

Process Development of the BACE Inhibitors BI 1147560 BS and BI 1181181 MZ

Published:2022-12-08 Issue:12 Volume:26 Page:3345-3372
ISSN:1083-6160
Container-title:Organic Process Research & Development
language:en
Short-container-title:Org. Process Res. Dev.

Author:

Li Guisheng¹,Tan Zhulin¹,Xu Yibo¹,Sidhu Kanwar P. S.¹,Qu Bo¹^ORCID,Herbage Melissa A.¹,Eriksson Magnus C.¹,Zeng Xingzhong¹,Busacca Carl A.¹,Desrosiers Jean-Nicolas¹,Hampel Thomas²,Niemeier Oliver²,Reichel Carsten²,Quynh Dang Mai Thi²,Schoerer Marvin²,Kemmer Dirk²,Eick Melanie²,Werle Holger²,Kim Soojin¹,Li Zhibin¹,Venkatraman Shankar³,Jia Lanqi³,Claremon David A.³,Fuchs Klaus⁴,Heine Niklas⁴,Byrne Denis¹,Narayanan Bikshandarkoil¹,Sarvestani Max¹,Johnson Joe¹,Premasiri Ajith¹,Nummy Larry J.¹,Lorenz Jon C.¹,Haddad Nizar¹^ORCID,Gonnella Nina C.¹^ORCID,Pennino Scott¹,Krawiec Mariusz¹,Senanayake Chris H.¹,Buono Frederic¹^ORCID,Lee Heewon¹,Hossain Azad¹,Song Jinhua J.¹,Reeves Jonathan T.¹^ORCID

Affiliation:

1. Departments of Chemical Development and Material and Analytical Sciences, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States

2. Chemical Process Development, Boehringer Ingelheim GmbH & Co KG, 55216 Ingelheim am Rhein, Germany

3. Vitae Pharmaceuticals, Inc., Fort Washington, Pennsylvania 19034, United States

4. Medicinal Chemistry, Boehringer Ingelheim Pharma GmbH & Co KG, 88397 Biberach an der Riss, Germany

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Physical and Theoretical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.oprd.2c00325

Reference62 articles.

1. 2021 Alzheimer's disease facts and figures

2. Alzheimer and his disease: a brief history

3. Comparative Analysis of Aducanumab, Zagotenemab and Pioglitazone as Targeted Treatment Strategies for Alzheimer’s Disease

4. Î²-secretase inhibitor; a promising novel therapeutic drug in Alzheimerâ€™s disease

5. aBukhtiyarov, Y.; Cacatian, S.; Dillard, L. W.; Dorner-Ciossek, C.; Fuchs, K.; Jia, L.; Lala, D. S.; Morales-Ramos, A.; Reeves, J.; Singh, S. B.; Venkatraman, S.; Xu, Z.; Yuan, J.; Zhao, Y.; Zheng, Y.; Rast, G. Inhibitors of β-Secretase. U.S. Patent 8,981,112 B2, 2015.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of Asymmetric Reductive Amination of Unfunctionalized Ketone with Primary Amine;Organic Process Research & Development;2024-05-22

2. Early Process Development and Scale-Up of a Positive Allosteric Modulator of the α7 Nicotinic Acetylcholine Receptor;Organic Process Research & Development;2024-02-07

3. Synthesis of (1R)‐1‐(4‐Bromophenyl)‐2,2,2‐trifluoroethan‐1‐amine Hydrochloride through Diastereoselective Trifluoromethylation of a Chiral Sulfinimine;Helvetica Chimica Acta;2023-09-21

4. Addition-elimination reactions of 2,2-disubstituted malononitriles and α-aryl nitriles. Subsequent transformations.;Arkivoc;2023-07-11

5. Synthesis of beta‐site amyloid precursor protein‐cleaving enzyme 1 inhibitors BI 1147560 and BI 1181181 labeled with carbon‐14 and deuterium;Journal of Labelled Compounds and Radiopharmaceuticals;2023-03-24